+44 (0)844 736 9016
info@mawdsleys.co.uk
+44 (0)844 736 9016
info@mawdsleys.co.uk
Mawdsleys is now the distributor of Manx Healthcare contract lines in England
Mawdsleys is now the distributor of Manx Healthcare contract lines in England 13th August 2020

Mawdsleys is delighted to be partnering with Manx Healthcare to distribute their contract products to hospitals in England.

 

Hospitals can view and check live stock levels and contract prices on Mawdsleys Online, and order in their normal way. For any queries hospitals can contact their Regional Hospital Account Manager or Mawdsleys Customer Services.

 

Other latest news
https://www.mawdsleys.co.uk/news/mawdsleys-and-oncoscience-launch-a-named-patient-program-for-cimaher-nimotuzumab-in-the-uk-and-ireland/ thumbnail image Mawdsleys and Oncoscience launch a Named Patient Program for CIMAher®

Mawdsleys and Oncoscience GMbH have launched a Named Patient Supply Program to allow Oncologists in the United Kingdom (UK) and Ireland to obtain access to CIMAher® (Nimotuzumab) on an unlicensed basis for the treatment of various types of cancer.   Nimotuzumab has been approved for marketing in 25 different countries worldwide for a variety of…

Read more
https://www.mawdsleys.co.uk/news/mawdsleys-and-meabco-launch-a-named-patient-supply-program-for-bp-c1/ thumbnail image Mawdsleys and Meabco launch a Named Patient Supply program for BP-C1

Mawdsleys and Meabco A/S have launched a Named Patient Supply program to allow Oncologists within the European Union (EU) to obtain access to BP-C1 on an unlicensed basis for the treatment of metastatic breast cancer and incurable pancreatic cancer.   BP-C1 is a new benzene-poly-carboxylic acids complex with cis-diammineplatinum (II)…

Read more